Ruiz-Picazo, A.; Colón-Useche, S.; Perez-Amorós, B.; González-Álvarez, M.; Molina-Martínez, I.; González-Álvarez, I.; García-Arieta, A.; Bermejo, M.
Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products. Pharmaceutics 2019, 11, 663.
https://doi.org/10.3390/pharmaceutics11120663
AMA Style
Ruiz-Picazo A, Colón-Useche S, Perez-Amorós B, González-Álvarez M, Molina-Martínez I, González-Álvarez I, García-Arieta A, Bermejo M.
Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products. Pharmaceutics. 2019; 11(12):663.
https://doi.org/10.3390/pharmaceutics11120663
Chicago/Turabian Style
Ruiz-Picazo, Alejandro, Sarin Colón-Useche, Blanca Perez-Amorós, Marta González-Álvarez, Irene Molina-Martínez, Isabel González-Álvarez, Alfredo García-Arieta, and Marival Bermejo.
2019. "Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products" Pharmaceutics 11, no. 12: 663.
https://doi.org/10.3390/pharmaceutics11120663
APA Style
Ruiz-Picazo, A., Colón-Useche, S., Perez-Amorós, B., González-Álvarez, M., Molina-Martínez, I., González-Álvarez, I., García-Arieta, A., & Bermejo, M.
(2019). Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products. Pharmaceutics, 11(12), 663.
https://doi.org/10.3390/pharmaceutics11120663